39
Views
4
CrossRef citations to date
0
Altmetric
Review

Determining antibiotic resistance in Helicobacter pylori

, &
Pages 267-272 | Published online: 09 Jan 2014

References

  • Dunn BE, Cohen H, Blaser MJ. Helicobacter pylori. Chn. Microbial Rev. 10(4), 720–741 (1997).
  • •A comprehensive review of H pylori, including pathogenesis, diagnosis and treatment.
  • Goodwin CS. Helicobacter pylori gastritis, peptic ulcer, and gastric cancer: clinical and molecular aspects. Chn. Infect. Dis. 25(5), 1017–1019 (1997).
  • Blaser MJ. Helicobacter pylori and gastric diseases. BMJ. 316(7143), 1507–1510 (1998).
  • Kuipers EJ, Thijs JC, Festen HP The prevalence of Helicobacter pylori in peptic ulcer disease. Aliment Pharmacol .Ther. 9(Suppl 2), 59–69 (1995).
  • Parsonnet J, Friedman GD, Vandersteen DP et al. Helicobacter pylori infection and the risk of gastric carcinoma N Engl. J Med. 325(16), 1127–1131 (1991).
  • Enroth H, Kraaz W Engstrand L et al. Helicobacter pylori strain types and risk of gastric cancer: a case-control study. Cancer Epidemial Biomarkers Prey. 9(9), 981–985 (2000).
  • Forman D, Newell DG, Fullerton F et al. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. BMI 302(6788), 1302–1305 (1991).
  • Correa P Helicobacter pylori and gastric carcinogenesis. Am. J Surg. Pathol 19(Suppl 1), S37–43 (1995).
  • Kuipers EJ. Review article: exploring the link between Helicobacter pylori and gastric cancer. Aliment Pharmacol Then 13 (Supp1.1), 3–11 (1999).
  • IARC. Infection with Helicobacter pylori. IARC Monogr Eval Carcinog. Risks Hum. 61,177-240 (1994). itGraham DY. Therapy of Helicobacter pylori: current status and issues. Gastroenterology 118(2 Suppl 1), S2-8 (2000).
  • de Boer WA, Tytgat GN. Regular review: treatment of Helicobacter pylori infection. BM/. 320(7226), 31–34 (2000).
  • Megraud E Epidemiology and mechanism of antibiotic resistance in Helicobacter pylori. Gastroenterology 115(5), 1278–1282 (1998).
  • Megraud F, Doermann HP Clinical relevance of resistant strains of Helicobacter pylori: a review of current data. Gut 43 (Supp1.1), S61-65 (1998).
  • Goodwin A, Kersulyte D, Sisson G et al. Metronidazole resistance in Helicobacter pylori is due to null mutations in a gene (rdxA) that encodes an oxygen-insensitive NADPH nitroreductase. Mot Microbial 28(2), 383–393 (1998).
  • JeongJY, Mukhopadhyay AK, Dailidiene D et al Sequential inactivation of rdxA (HP0954) and frxA (HP0642) nitroreductase genes causes moderate and high-level metronidazole resistance in Helicobacter pylori. J Bacterial 182(18), 5082–5090 (2000).
  • Versalovic J, Shortridge D, Kibler K et al Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrob. Agents Chemother. 40(2), 477–480 (1996).
  • ••The first report on the association ofmutations in 23S rRNA with clarithromycin-resistance in H pylori.
  • Versalovic J, Osato MS, Spakovsky K et al Point mutations in the 23S rRNA gene of Helicobacter pylori associated with different levels of clarithromycin resistance. J Antimicrob. Chemother. 40(2), 283–286 (1997).
  • Occhialini A, Urdaci M, Doucet-Populaire F et al. Macrolide resistance in Helicobacter pylori: rapid detection of point mutations and assays of macrolide binding to ribosomes. Antimicrob. Agents Chemother. 41(12), 2724–2728 (1997).
  • Hulten K, Gibreel A, Skold 0 et al. Macrolide resistance in Helicobacter pylori: mechanism and stability in strains from clarithromycin-treated patients. Antimicrob. Agents Chemother. 41(11), 2550–2553 (1997).
  • Glupczynski Y, Megraud F, Lopez-Brea M et al. European multicentre survey of in vitro antimicrobial resistance in Helicobacter pylori. Eur. j Chn. Microbial Infect. Dis. 20(11), 820–823 (2001).
  • Torres J, Camorlinga-Ponce M, Perez-Perez G et al Increasing multidrug resistance in Helicobacter pylori strains isolated from children and adults in Mexico. J Chn. Microbial 39(7), 2677–2680 (2001).
  • Dore MP, Piana A, Carta M et at Amoxycillin resistance is one reason for failure of amoxycillin-omeprazole treatment of Helicobacter pylori infection. Aliment Pharmacol Then 12(7), 635–639 (1998).
  • Dore MP, Osato MS, Realdi G et aZ Amoxycillin tolerance in Helicobacter pylori. J Antimicrob. Chemothen 43(1), 47–54(1999).
  • Dore MP, Graham DY, Sepulveda AR Different penicillin-binding protein profiles in amoxicillin-resistant Helicobacter pylori. Helicobacter 4(3), 154–161(1999).
  • Glupczynski Y, Labbe M, Hansen Wet al. Evaluation of the E test for quantitative antimicrobial susceptibility testing of Helicobactenpyloni.j Clin. Microbial 29(9), 2072-2075 (1991).
  • Szczebara F, Dhaenens L, Vincent P et al. Evaluation of rapid molecular methods for detection of clarithromycin resistance in Helicobacter pylori. Eur. j Clin. Microbial Infect. Dis. 16(2), 162–164 (1997).
  • Li C, Ha T, Chi DS et al. Differentiation of Helicobacter pylori strains directly from gastric biopsy specimens by PCR-based restriction fragment length polymorphism analysis without culture. Clin. Microbial 35(12), 3021–3025 (1997).
  • Bjorkholm B, Befits R, Jaup B et al. Rapid PCR detection of Helicobacter pylori-associated virulence and resistance genes directly from gastric biopsy material." (lin. Microbial 36(12), 3689–3690 (1998).
  • Sevin E, Lamarque D, Delchier JC et al. Co-detection of Helicobacter pylori and of its resistance to clarithromycin by PCR FEMS Microbial Lett. 165(2), 369–372 (1998).
  • Maeda S, Yoshida H, Ogura K et al Helicobacter pylori specific nested PCR assay for the detection of 23S rRNA mutation associated with clarithromycin resistance. Gut 43(3), 317–321 (1998).
  • Alarcon T, Domingo D, Prieto N et al. PCR using 3'-mismatched primers to detect A2142C mutation in 23S rRNA conferring resistance to clarithromycin in Helicobacter pylori clinical isolates. J. Clin. Microbial 38(2), 923–925 (2000).
  • Ge Z, Taylor DE. Rapid polymerase chain reaction screening of Helicobacter pylori chromosomal point mutations. Helicobacter 2(3), 127–131 (1997).
  • Pina M, Occhialini A, Monteiro Let al. Detection of point mutations associated with resistance of Helicobacter pylori to clarithromycin by hybridization in liquid phase." (lin. Microbial 36(11), 3285–3290 (1998).
  • Marais A, Monteiro L, Occhialini A et al. Direct detection of Helicobacter pylori resistance to macrolides by a polymerase chain reaction/DNA enzyme immunoassay in gastric biopsy specimens. Gut 44(4), 463–467 (1999).
  • van Doom Q, Glupczynski Y, Kusters JG et al. Accurate prediction of macrolide resistance in Helicobacter pylori by a PCR line probe assay for detection of mutations in the 23S rRNA gene: multicenter validation study. Antimicrob. Agents Chemother. 45(5), 1500–1504 (2001).
  • •A multicenter validation study of the PCR-line probe assay for detection of clarithromycin resistance mutations.
  • Landegren U, Kaiser R, Sanders J et al. A ligase-mediated gene detection technique. Science 241(4869), 1077–1080 (1988).
  • Stone GG, Shortridge D, Versalovic J et al. A PCR-oligonucleotide ligation assay to determine the prevalence of 23S rRNA gene mutations in clarithromycin-resistant Helicobacter pylori. Antimicrob. Agents Chemother. 41(3), 712–714 (1997).
  • Wittwer CT, Ririe KM, Andrew RV et al. The LightCycler: a microvolume rnultisample fluorimeter with rapid temperature control. Bio7i•chniques 22(1), 176–181 (1997).
  • Gibson JR, Saunders NA, Burke B et al. Novel method for rapid determination of clarithromycin sensitivity in Helicobacter pylori. J. (lin. Microbial 37(11), 3746–3748 (1999).
  • Chisholm SA, Owen RJ, Teare EL et al. PCR-based diagnosis of Helicobacter pylori infection and real-time determination of clarithromycin resistance directly from human gastric biopsy samples. J. (Yin. Microbial 39(4), 1217–1220 (2001).
  • •Application of real-time PCR technology directly on biopsy samples.
  • Matsumura M, Hikiba Y, Ogura K et al. Rapid detection of mutations in the 23S rRNA gene of Helicobacter pylori that confers resistance to clarithromycin treatment to the bacterium. J. (Yin. Microbial 39(2), 691–695 (2001).
  • Bjorkholm BM, Oh JD, Falk PG et al. Genomics and proteomics converge on Helicobacter pylori. Curr. Opin. Microbial 4(3), 237–245 (2001).
  • Southern E, Mir K, Shchepinov M. Molecular interactions on microarrays. Nature Genet. 21(1 Suppl.), 5–9 (1999).
  • Hacia JG. Resequencing and mutational analysis using oligonucleotide microarrays. Nature Genet. 21(1 Suppl), 42–47 (1999).
  • Duggan DJ, Bittner M, Chen Yet al. Expression profiling using cDNA microarrays. Nature Genet. 21(1 Suppl), 10–14 (1999).
  • Salama N, Guillemin K, McDaniel TK et al. A whole-genome microarray reveals genetic diversity among Helicobacter pylori strains. Proc. Natl Acad. Sci. USA 97(26), 14668–14673 (2000).
  • •The first published report on using whole-genome microarrays for determining different genotypes of H pylori.
  • Trebesius K, Panthel K, Strobel S et al. Rapid and specific detection of Helicobacter pylori macrolide resistance in gastric tissue by fluorescent in situ hybridisation. Gut 46(5), 608–614 (2000).
  • Russmann H, Kempf VA, Koletzko S et al. Comparison of fluorescent in situ hybridization and conventional culturing for detection of Helicobacter pylori in gastric biopsy specimens.' Clin. Microbial 39(1), 304–308 (2001).
  • •Fluoroscent in situ hybridization for combined detection and clarithromycin resistance testing of H pylori in gastric biopsy specimens.
  • Russmann H, Adler K, Haas R et al. Rapid and accurate determination of genotypic clarithromycin resistance in cultured Helicobacter pylori by fluorescent in situ hybridization. J. Clin. Microbial 39(11), 4142–4144 (2001).
  • Sanger F, Nicklen S, Coulson AR DNA sequencing with chain-terminating inhibitors. Proc. Natl Acad. Sci. USA 74(12), 5463–5467 (1977).
  • Ronaghi M, Uhlen M, Nyren P. A sequencing method based on real-time pyrophosphate. Science 281(5375), 363–365 (1998).
  • •Description of a novel DNA sequencing technology.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.